Paula Cannon

Viruses, stem cells, gene therapy.

[Paula Cannon @PaulaUSC]

Twitter account now dormant. Follow me on Bluesky @uscprof.bsky.social

[ASGCT @ASGCTherapy]

Don’t miss today’s George Stamatoyannopoulos Memorial Symposium featuring three visionary keynote speakers:
🔹Paula Cannon, PhD: Designing what nature can’t: Cell and gene therapy for HIV
🔹Erik Sontheimer, PhD: CRISPR, from bacterial immunity to genome editing therapeutics
🔹Beverly Davidson, PhD: Outstanding Achievement Award Recipient

We'll also be celebrating the recipients of the George Stamatoyannopoulos Mentorship Award, the Excellence in Research Award, and the Mavis Agbandje-McKenna Scholarship and Fund. See you there!

Session details: https://t.co/3HetXJ9dHl

[Keck School of Medicine of USC @KECKSchool_USC]

Dean's POV 📸 Proud to welcome our 2026 commencement speakers: Elena Fuentes-Afflick, MD, MPH, Chief Scientific Officer of the AAMC, for our MD and clinical programs ceremony, and Paula Cannon, PhD, Distinguished Professor and CRISPR pioneer, for our graduate programs. #KSOMGrad

[ASGCT @ASGCTherapy]

We recently hosted a Congressional briefing on #GeneTherapy approaches for #HIV with experts from @USC, @OHSUNews, and patient advocates. Read our recap to learn how decades of NIH-funded research is bringing us closer to a cure: https://t.co/lwHtrnJCi7 #ASGCTAdvocacy

[ASGCT @ASGCTherapy]

Thank you @FDA, Vinayak Prasad MD, & @DrMakaryFDA for convening a thoughtful #CGT roundtable today. ASGCT leaders Terry Flotte MD & @PaulaUSC MD joined peers in this future-forward discussion. Watch at 13:07 & 1:07:25: https://t.co/rBwfIcNkD1
#GeneTherapy #CellTherapy #MedTwitter

[Paula Cannon @PaulaUSC]

I'll be giving a COVID update at the LA City Health Commission Meeting tonight https://t.co/szFRo2AxRN

[Paula Cannon @PaulaUSC]

ASGCT is an amazing organization, with fantastic staff and volunteer members. I’m going to try really hard not to break it in my year as president 😊

[Keck School of Medicine of USC @KECKSchool_USC]

👏 Join us in congratulating Distinguished Professor Paula Cannon (@PaulaUSC), PhD, for her appointment as president of @ASGCTherapy, the organization dedicated to developing next-generation therapies that address the underlying causes of disease. https://t.co/qSS3wKmsd5

[Paula Cannon @PaulaUSC]

I’m excited about the potential for B to be a new frontier in cell therapies.

[Be Biopharma @bebiopharma]

We're excited to announce the appointment of @PaulaUSC to our Scientific Advisory Board. Dr. Cannon will work alongside other members of the scientific advisory board to provide guidance to advance Be Bio’s novel engineered B Cell medicines (BCMs). https://t.co/JOVlrUZ4ys

[ASGCT @ASGCTherapy]

Wow, what a week at #ASGCT2024!

We hope you learned from the science, met fellow members, and saw some great presentations this week!

THANK YOU, everyone! See you in New Orleans next year!

[Vipin M. Vashishtha @vipintukur]

A new study finds that people with #LongCOVID have distinct patterns of inflammation detectable in the blood, which could potentially be targeted with immune therapies. The findings confirm that LongCOVID leads to ongoing inflammation which can be detected in the blood. 1/

[Fyodor Urnov @UrnovFyodor]

This is an outrage and a profound injustice.
https://t.co/PkepFADE2U
The @igisci @DanaherCorp Beacon for CRISPR Cures is not run by the naive - we are all realists and veterans of developing gene editing medicines in the real world.
We are confident in our ability to develop, and deliver for all to use, a scalable, portable, affordable approach to develop and provide gene editing medicines for neurologic diseases treatable by repairing blood stem cells - such as the one this child is suffering from. #HealthJustice

[ASGCT @ASGCTherapy]

Get ready for DAY 3 of #ASGCT23 with Rayne Rouce, MD (@bcmhouston) and Paula Cannon, PhD (@PaulaUSC): https://t.co/Ihb12NtQDC! Hear the highlights of their second day—and what they're looking forward to at the Annual Meeting and in Los Angeles.

[David G. Armstrong follow @dgarmstrong.bsky.social @DGArmstrong]

The great and good @USC Distinguished Prof. Paula Cannon in Mid-Gesticulation (and pre-eyeroll) with SVP Prof. @ikpuri following @PresidentFolt superb and inspiring State of @USC address @KECKSchool_USC #FightOn #HealOn

[Global Gene Therapy Initiative @globalgti]

Can we reprogram B cells to make custom antibodies that can block many strains of #HIV?

Through her work with @rid_hiv, @PaulaUSC found her answer: yes we can, at least in the lab. Now they have to see if this can also work in animal models.

https://t.co/ABKnTCW210

#hivcure

[Prof Peter Hotez MD PhD DSc(hon) @PeterHotez]

Bottom line: antiscience aggression and disinformation was a leading cause of death in the United States 🇺🇸 in 2021 and 2022. Antiscience aggression kills more Americans than just about any other societal force.

[Daily Trojan @dailytrojan]

Keck Medicine of USC and the USC Student Health Center received the “LGBTQ+ Healthcare Equality Leader” title in March. Keck Medicine’s gender-affirming care played a big factor in the rating.

https://t.co/swVeJcvJSq

[Paula Cannon @PaulaUSC]

Thinking through the holidays this year, by @dr_kkjetelina https://t.co/AsXJdVqUKN

[Daily Trojan @dailytrojan]

The Association of American Universities elected USC President Carol Folt as chair of their Board of Directors Tuesday. Folt will now publicly spearhead AAU projects and act as the leading spokesperson for the association.

https://t.co/ll7OdFCB7Y

[Nature Biotechnology @NatureBiotech]

Our annual survey of the best #NBTAcademicStartups in 2021 continues with @chromamedicine and @tunetx_news, two companies using epigenome editing for precision medicine https://t.co/871umTUHjg

[Paula Cannon @PaulaUSC]

Excited to join Chroma’s SAB, as they develop a new class of gene medicines based on turning bad genes off and good genes on.

[Chroma Medicine @chromamedicine]

Meet our Scientific Advisory Board: This team of renowned leaders in #Epigenetics, cell & #GeneTherapy & synthetic biology will be invaluable as we advance our platform toward bringing single-dose genomic therapeutics to patients.

Read more: https://t.co/31ug9tN3ap